Telo Genomics Ownership

Stocks . Canada . 
Stock . Telo Genomics Corp
TELO Stock  CAD 0.12  0.01  9.09%   
Telo Genomics Corp shows a total of 74.56 Million outstanding shares. Telo Genomics Corp has 5.34 % of its outstanding shares held by insiders and 2.74 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2012-03-31
Previous Quarter
71.3 M
Current Value
71.3 M
Avarage Shares Outstanding
33.7 M
Quarterly Volatility
25.8 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Telo Genomics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Telo Genomics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to climb to -0.19 in 2024. Common Stock Shares Outstanding is likely to climb to about 72.6 M in 2024, whereas Net Loss is likely to drop (2.5 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Telo Stock Ownership Analysis

The company recorded a loss per share of 0.04. Telo Genomics Corp last dividend was issued on the 22nd of November 2019. The entity had 1:5 split on the 22nd of November 2019. Telo Genomics Corp., a personalized medicine company, focuses on the development and commercialization of predictive technological products. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. TELO GENOMICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange. To find out more about Telo Genomics Corp contact the company at 416 673 8487 or learn more at https://www.telodx.com.

Telo Genomics Outstanding Bonds

Telo Genomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Telo Genomics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Telo bonds can be classified according to their maturity, which is the date when Telo Genomics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
Volcan Compania Minera Corp Bond
USP98047AC08		View
Boeing Co 2196 Corp Bond
US097023DG73		View
MPLX LP 4875 Corp Bond
US55336VAG59		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View
Morgan Stanley 3971 Corp Bond
US61744YAL20		View

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Telo Stock Analysis

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY